Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Department of Infectious Diseases and Microbiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA.
J Infect Dis. 2023 Oct 18;228(Suppl 6):S376-S389. doi: 10.1093/infdis/jiac338.
Research directed at select prototype pathogens is part of the approach put forth by the National Institute of Allergy and Infectious Disease (NIAID) to prepare for future pandemics caused by emerging viruses. We were tasked with identifying suitable prototypes for four virus families of the Bunyavirales order (Phenuiviridae, Peribunyaviridae, Nairoviridae, and Hantaviridae). This is a challenge due to the breadth and diversity of these viral groups. While there are many differences among the Bunyavirales, they generally have complex ecological life cycles, segmented genomes, and cause a range of human clinical outcomes from mild to severe and even death. Here, we delineate potential prototype species that encompass the breadth of clinical outcomes of a given family, have existing reverse genetics tools or animal disease models, and can be amenable to a platform approach to vaccine testing. Suggested prototype pathogens outlined here can serve as a starting point for further discussions.
针对选定原型病原体的研究是美国国立过敏和传染病研究所(NIAID)为应对由新兴病毒引起的未来大流行而提出的方法的一部分。我们的任务是确定布尼亚病毒目(Phenuiviridae、Peribunyaviridae、Nairoviridae 和 Hantaviridae)中四个病毒科的合适原型。由于这些病毒组的广泛和多样性,这是一个挑战。虽然布尼亚病毒目中有许多差异,但它们通常具有复杂的生态生命周期、分段基因组,并导致一系列人类临床结果,从轻症到重症甚至死亡。在这里,我们划定了具有给定家族广泛临床结果的潜在原型种,具有现有的反向遗传学工具或动物疾病模型,并且可以采用平台方法进行疫苗测试。这里概述的建议原型病原体可以作为进一步讨论的起点。